Back to Headlines
Health
Jun 15, 2026
Analyzed by Llama- 4 Scout 17B 16E Instruct

Lupus Patients in England Achieve Remission with Pioneering GM Therapy

AI Summary
Five lupus patients in England have achieved remission after being treated with a revolutionary GM therapy that genetically modifies their own cells. The therapy, known as CAR T-cell therapy, involves removing and engineering T lymphocytes to spot and destroy disease.

The Breakthrough in Lupus Treatment

Five lupus patients in England are in remission after being treated with a revolutionary therapy that genetically modifies their own cells, in a medical breakthrough that could offer people a cure, doctors have said.

Understanding CAR T-cell Therapy

CAR (chimeric antigen receptor) T-cell therapy involves removing a type of white blood cell also called T lymphocytes, which are crucial for hunting out infected or damaged cells, and engineering them to spot and destroy disease. The T-cells are then fed back into the patient via an infusion to reset their immune system.

The NHS Trial

In an NHS trial led by University College London hospitals foundation trust (UCLH) and University College London (UCL), nine patients with severe lupus were recruited. They had not previously responded to any treatments. Most had lupus nephritis, a serious complication involving the kidneys.

  • Six patients received a lower dose of CAR-T and three got a higher dose.
  • Five of those on the lower dose, who were followed up for an average of 11 months, went into remission within just a few months.

The Impact on Patients

One of the five patients, Katie Tinkler, said she no longer had any of the main symptoms of the disease more than three decades after her diagnosis. She has also skied for the first time in a decade and was able to dance at her daughter’s wedding.

The Future of Lupus Treatment

Prof Karl Peggs, the director of UCLH’s biomedical research centre, said that while larger studies were needed, CAR T-cell therapy could offer people the chance of a cure. “These findings are truly groundbreaking and offer fresh hope to people living with lupus,” he said.